“We must have early and accurate diagnosis with the utilization of essential Single-Photon Emission Computerized Tomography (SPECT) products before we can have treatment with the next generation of tumor specific agents.”
Targeting somatostatin receptors
- High expression in NETs.
- Present in certain brain tumors
- Subsets of other cancers like prostate cancer
- Diagnostic and therapeutic implications